Other News

Dr. Scott D. James Becomes Leading Physician of The Vascular Care Group, Plymouth

Decorated vascular surgeon Dr. James brings over two decades of experience to outpatient care center PLYMOUTH, Mass.–(BUSINESS WIRE)–The Vascular Care Group (TVCG), announced today the opening of a new, state-of-the-art vascular center, located in Plymouth, Mass. Scott D. James, DO, RPVI will serve as the center’s lead vascular surgeon, bringing over […]

Intravascular Imaging Incorporated (“i3”) Announces Launch of Its 3-French NIRF-IVUS Imaging Catheter Intended for Human Coronary Imaging, with Favorable Tests in Ex-Vivo Human Coronaries, and Launch of Series A Financing

Molecular and Pathophysiologic Imaging of Coronary Disease, Dissections and Unhealed Stents Expands Therapeutic Options by Combining Intravascular Ultrasound (IVUS) and Near-Infrared Fluorescence (NIRF) Imaging. BOSTON, and WILTON, Conn., July 18, 2022 /PRNewswire/ — I3 today announced the launch of its proprietary 3-French NIRF-IVUS Catheter designed in collaboration with the Massachusetts General Hospital. The device […]

Ra Medical Systems Appoints Brian D. Conn Interim Chief Financial Officer

CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the appointment of Brian D. Conn as interim Chief Financial Officer, effective immediately. Mr. Conn will serve as the Company’s Principal […]

Pulnovo Medical Concludes Successfully First Pre-Sub Meeting with FDA for PADN Global Clinical Trial

SHANGHAI, July 15, 2022 /PRNewswire/ — Pulnovo Medical Limited, a globally recognized device pioneer in the treatment for cardiopulmonary diseases, today announced that it has successfully concluded the first Pre-Sub meeting with the U.S. Food and Drug Administration (“FDA”) for its Pulmonary Artery Denervation (PADN) Global Trial. Dr. Shaoliang Chen, Chair of Pulnovo […]

Maxwell Biomedical announced that it has initiated its First-In-Human Clinical Trial “Initial Experience with Spatial Resynchronization Therapy in Patients with Atrial Fibrillation (SR-TheAF)”

Maxwell Biomedical announced that it has initiated its First-In-Human Clinical Trial “Initial Experience with Spatial Resynchronization Therapy in Patients with Atrial Fibrillation (SR-TheAF)” continue reading the article here.

PIH Health Good Samaritan Hospital First in LA to Use Next-Generation Evolut™ FX TAVR System

Evolut FX TAVR System Used to Treat Patient with Symptomatic Severe Aortic Stenosis LOS ANGELES, July 13, 2022 /PRNewswire/ — PIH Health Good Samaritan Hospital is the first hospital in Los Angeles to treat patients with the next-generation, self-expanding Evolut FX Transcatheter Aortic Valve Replacement (TAVR) System, a minimally invasive alternative to open-heart surgical aortic […]

Cordis Announces Start of Enrollment in RADIANCY Clinical Study in Europe

Multi-center study to evaluate safety and efficacy of S.M.A.R.T. RADIANZ™ Vascular Stent System via Radial Access MIAMI LAKES, Fla., July 14, 2022 /PRNewswire/ — Cordis, a global leader in cardiovascular technologies, today announced the start of the RADIANCY pre-market clinical study in Europe. It is a prospective, multi-center, single-arm study to assess the […]

InspireMD Announces Appointment of Endovascular Pioneer Dr. Juan Parodi as Strategic Advisor

Credited with performing the first ever endovascular repair procedure in 1990 TEL AVIV, Israel, July 14, 2022 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke, today announced the appointment of endovascular pioneer Dr. Juan Parodi as a strategic […]

SoniVie Announces successful procedure with TIVUS system on first patient enrolled for REDUCED1 Pilot study

TEL AVIV, Israel, July 13, 2022 /PRNewswire/ — SoniVie, an Israeli company developing a novel proprietary Therapeutic Intra-Vascular Ultrasound (TIVUS™) System to treat a variety of hypertensive disorders, announced that on May 30th 2022 the first patient was treated with its Renal Artery Denervation TIVUS™ technology, as part of the recently FDA IDE-approved Pilot […]

Intratech Medical enrolls patients to first ever human study for treatment of accute heart attacks using Booster™ – coronary sinus spiral balloon therapy

TEL AVIV, Israel, July 13, 2022 /PRNewswire/ — Intratech Medical, developer of the Booster™ spiral balloon therapy for the treatment of AMI patients, announced the successful enrollment of two patients in a multi-center first in human study to assess the safety and technical performance of their Booster balloon in the treatment of patients […]